DB17555InvestigationalProtein Based Therapies
SEA-CD70 is an investigational humanized, non-fucosylated monoclonal antibody targeting CD70. SEA-CD70 is under investigation in clinical trial NCT04227847 (A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies).
- Code names
- PF-08046040 · SEA-CD70
What you can answer from here — as of May 06, 2026
Which companies are running trials of PF-08046040, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account